Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
ResMed Inc. has filed a notice for the proposed sale of securities under Rule 144, indicating that Brett Sandercock, an officer of the company, plans to sell 1,000 shares of common stock. The aggregate market value of these shares is approximately $215,580, and the sale is scheduled for April 8, 2025, on the NYSE. This move follows previous sales by Sandercock in the past three months, reflecting a strategic decision that may impact the company’s stock liquidity and investor perception.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, specializing in the development and manufacturing of equipment related to sleep disorders and respiratory care. The company is known for its innovative solutions in sleep apnea treatment and has a strong market presence in medical devices that enhance the quality of life for patients with chronic respiratory conditions.
YTD Price Performance: -8.80%
Average Trading Volume: 1,250,508
Technical Sentiment Signal: Sell
Current Market Cap: A$50.09B
See more data about RMD stock on TipRanks’ Stock Analysis page.